Aurorix

moclobemide

A reversible mono-amine oxidase inhibitor (MAOI) used to manage depression and performance anxiety. It is not approved for use in the USA.
 
Adverse effects
Insomnia, headache, dizziness.

Aurorix®

Moclobemide, see there.
Mentioned in ?
References in periodicals archive ?
Its major drugs include Accutane for acne vulgaris, Aurorix for depression, Actemra for rheumatoid arthrritis, Boniva for osteopososis, Cellcept for transplant rejection and Dilatrend for hypertension.
Lurasidone * Latuda Mirtazapine * Remeron Moclobemide * Amira, Aurorix, Clobemix, Depnil, Manerix Modafinil * Provigil Olanzapine/fluoxetine * Symbyax Paroxetine * Paxil Phenelzine * Nardil Pramipexole * Mirapex Quetiapine * Seroquel Riluzole * Rilutek Sertraline * Zoloft Vortioxetine * Brintellix
The EUR120m transaction, initially announced in August, covers world-wide rights to Marcoumar, Torem, Tilcotil and Aurorix, which together represent annual sales of some SEK500m.
Aurorix (moclobemide) is an MAO-A inhibitor and a well-known antidepressant prescribed by specialists.
The EUR120m deal covers the world-wide rights to Marcoumar, Torem, Tilcotil and Aurorix, which together represent annual sales of some SEK500m.